These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 1168136)

  • 1. Narcotic withdrawal like mouse jumping produced by amphetamine and L-DOPA.
    Lal H; Colpaert FC; Laduron P
    Eur J Pharmacol; 1975 Jan; 30(1):113-6. PubMed ID: 1168136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anorexigenic effects of d-amphetamine and l-DOPA in the rat.
    Sanghvi IS; Singer G; Friedman E; Gershon S
    Pharmacol Biochem Behav; 1975; 3(1):81-6. PubMed ID: 1129359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potentiation of jumping behavior by aminophylline in mice treated with threshold doses of amphentamine and dopa.
    Colpaert FC; Lal H
    Res Commun Chem Pathol Pharmacol; 1974 Nov; 9(3):587-90. PubMed ID: 4445575
    [No Abstract]   [Full Text] [Related]  

  • 4. The effect of L-dopa and (+)-amphetamine on the locomotor activity after pimozide and phenoxybenzamine.
    Maj J; Sowinska H; Kapturkiewicz Z; Sarnak J
    J Pharm Pharmacol; 1972 May; 24(5):412-4. PubMed ID: 4403816
    [No Abstract]   [Full Text] [Related]  

  • 5. Reversal by a central antiacetylcholine drug of pimozide-induced inhibition of mouse-jumping in amphetamine-dopa treated mice.
    Colpaert FC; Wauquier A; Niemegeers C; Lal H
    J Pharm Pharmacol; 1975 Jul; 27(7):536-7. PubMed ID: 239163
    [No Abstract]   [Full Text] [Related]  

  • 6. Behavioural and biochemical interaction between caffeine and L-dopa.
    Strömberg U; Waldeck B
    J Pharm Pharmacol; 1973 Apr; 25(4):302-8. PubMed ID: 4146682
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of the locomotor stimulant mechanisms of action of d-amphetamine and d-amphetamine plus l-dopa: possible involvement of serotonin.
    Neuburg J; Thut PD
    Biol Psychiatry; 1974 Apr; 8(2):139-50. PubMed ID: 4276374
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of neuroleptic drugs on mouse jumping induced by L-DOPA in amphetamine treated mice.
    Lal H; Marky M; Fielding S
    Neuropharmacology; 1976 Nov; 15(11):669-71. PubMed ID: 1034243
    [No Abstract]   [Full Text] [Related]  

  • 9. Modification of striatal acetylcholine concentration by dopamine receptor agonists and antagonists.
    Sethy VH; VAN Woert MH
    Res Commun Chem Pathol Pharmacol; 1974 May; 8(1):13-28. PubMed ID: 4847901
    [No Abstract]   [Full Text] [Related]  

  • 10. Neuroleptic drugs block both the hyperactivity and the increase in caudate nucleus cyclic AMP concentration produced by the administration of tranylcypromine and L-dopa to rats.
    Heal DJ; Green AR; Bloomfield MR; Grahame-Smith DG
    Psychopharmacology (Berl); 1978 Apr; 57(2):193-7. PubMed ID: 26101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic L-DOPA treatment of mice: a behavioural and biochemical study.
    Bailey R; Crisp E; Jackson DM; Jenkins O
    J Neural Transm; 1981; 50(2-4):209-24. PubMed ID: 6787171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modification by L-DOPA methylester (H 19-61) of amphetamine-induced brain catecholamine changes, thermal responses and toxicity in developing mice.
    Alhava E
    Acta Pharmacol Toxicol (Copenh); 1973; 33(5):330-47. PubMed ID: 4801079
    [No Abstract]   [Full Text] [Related]  

  • 13. Supersensitivity to dopaminergic agonists induced by haloperidol.
    Thornburg JE; Moore KE
    Natl Inst Drug Abuse Res Monogr Ser; 1975 Nov; (3):23-8. PubMed ID: 1241913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on the mechanism of post-etorphine catalepsy. Modyfying effect of amphetamine, apomorphine and dihydroxy-phenylalanine (L-dopa) on etorphine-induced concentrations of dopamine and noradrenaline in the rat central nervous system.
    Kania BF
    Acta Physiol Pol; 1979; 30(2):279-87. PubMed ID: 572616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Significance of catecholamines for the manifestation of morphine withdrawal in the rat].
    Bläsig J; Papeschi R; Herz A
    Arzneimittelforschung; 1974 Jul; 24(7):1015-6. PubMed ID: 4408108
    [No Abstract]   [Full Text] [Related]  

  • 16. Brain catecholamine concentration during the first week of development in rats.
    Phelps CP; Korányi L; Tamásy V
    Dev Neurosci; 1982; 5(5-6):503-7. PubMed ID: 7160315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Behavioral differences between neonatal and adult 6-hydroxydopamine-treated rats to dopamine agonists: relevance to neurological symptoms in clinical syndromes with reduced brain dopamine.
    Breese GR; Baumeister AA; McCown TJ; Emerick SG; Frye GD; Crotty K; Mueller RA
    J Pharmacol Exp Ther; 1984 Nov; 231(2):343-54. PubMed ID: 6149306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Relationship between gnawing compulsion and central dopaminergic mechanism in guinea pigs (author's transl)].
    Uemura H
    Nihon Yakurigaku Zasshi; 1979 Jan; 75(1):61-72. PubMed ID: 571393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of L-DOPA on brain catecholamines and motility in rats.
    Maj J; Grabowska M; Mogilnicka E
    Psychopharmacologia; 1971; 22(2):162-71. PubMed ID: 5124189
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of L-dopa on the locomotor activity of rats pretreated with 6-hydroxydopamine.
    Uretsky NJ; Schoenfeld RI
    Nat New Biol; 1971 Dec; 234(48):157-9. PubMed ID: 5289320
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.